Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.

Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.
复制标题

DOI:
10.1038/onc.2012.190
复制
发表时间:
2013-03-28
期刊:
影响因子:
8
通讯作者:
Stratakis, C. A.
Stratakis, C. A.
中科院分区:
医学1区
文献类型:
--
作者:
Palumbo, T.;Faucz, F. R.;Azevedo, M.;Xekouki, P.;Iliopoulos, D.;Stratakis, C. A.

文献摘要

参考文献

被引文献

相似文献

microRNA参与了多种肿瘤的发病机制,但其在垂体肿瘤发生中的作用仍不清楚。环磷酸腺苷(cAMP)依赖性蛋白激酶(PKA)缺陷型垂体在PKA主要调节亚基PRKAR 1A单倍不足引起的增生背景下偶尔形成侵袭性生长激素(GH)分泌型垂体瘤。这种发展的分子基础仍然未知。我们已经确定了垂体瘤在增生背景下形成的17-microRNA特征(一半病例由PRKAR 1A突变引起)。通过功能筛选分析,我们筛选出两种microRNA:抑制miR-26 b表达和上调miR-128表达可抑制垂体瘤细胞殖民地形成能力和侵袭能力。此外,我们发现miR-26 b和miR-128分别通过调节其直接靶点PTEN和BMI 1影响垂体瘤细胞的行为。此外,我们发现miR-128通过BMI 1直接结合在PTEN启动子上影响垂体瘤细胞中的PTEN表达水平和AKT活性。综上所述,我们已经确定了产生GH的垂体肿瘤的microRNA特征,并发现miR-26 b和miR-128调节这些肿瘤中PTEN-AKT通路的活性。这是第一个提示,在增生或生殖系PRKAR 1A缺陷的背景下,调节PTEN-AKT通路的microRNA可能参与GH产生性垂体瘤的形成。
MicroRNAs have been involved in the pathogenesis of different types of cancer, however their function in pituitary tumorigenesis remains poorly understood. Cyclic-AMP (cAMP)-dependent protein kinase (PKA)-defective pituitaries occasionally form aggressive growth-hormone (GH)-producing pituitary tumors in the background of hyperplasia caused by haploinsufficiency of the PKA’s main regulatory subunit, PRKAR1A. The molecular basis for this development remains unknown. We have identified a 17-microRNA signature of pituitary tumors formed in the background of hyperplasia (caused in half of the cases by PRKAR1A-mutations). We selected two microRNAs on the basis of their functional screen analysis: inhibition of miR-26b expression and up-regulation of miR-128 suppressed the colony formation ability and invasiveness of pituitary tumor cells. Furthermore, we identified that miR-26b and miR-128 affected pituitary tumor cell behavior through regulation of their direct targets, PTEN and BMI1, respectively. In addition, we found that miR-128 through BMI1 direct binding on the PTEN promoter affected PTEN expression levels and AKT activity in the pituitary tumor cells. Taken together, we have identified a microRNA signature for GH-producing pituitary tumors and found that miR-26b and miR-128 regulate the activity of the PTEN-AKT pathway in these tumors. This is the first suggestion of the possible involvement of microRNAs regulating the PTEN-AKT pathway in GH-producing pituitary tumor formation in the context of hyperplasia or due to germline PRKAR1A defects.
DOI: 10.1016/j.cell.2011.10.043
发表时间: 2011-12-09
期刊: Cell
影响因子: 64.5
作者:
Hatziapostolou M;Polytarchou C;Aggelidou E;Drakaki A;Poultsides GA;Jaeger SA;Ogata H;Karin M;Struhl K;Hadzopoulou-Cladaras M;Iliopoulos D
通讯作者: Iliopoulos D
DOI: 10.1002/jcp.20282
发表时间: 2005-07-01
影响因子: 5.6
作者:
Bottoni, A;Piccin, D;Uberti, ECD
通讯作者: Uberti, ECD
DOI: 10.1158/0008-5472.can-05-1783
发表时间: 2005-08-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Iorio, MV;Ferracin, M;Croce, CM
通讯作者: Croce, CM
DOI: 10.1158/0008-5472.can-08-2629
发表时间: 2008-11-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Godlewski, Jakub;Nowicki, Michal O.;Lawler, Sean
通讯作者: Lawler, Sean
DOI: 10.1158/1078-0432.ccr-08-1818
发表时间: 2009-04-01
影响因子: 11.5
作者:
Bandres, Eva;Bitarte, Nerea;Garcia-Foncillas, Jesus
通讯作者: Garcia-Foncillas, Jesus